Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome
- PMID: 33766516
- PMCID: PMC8429205
- DOI: 10.1016/j.ajog.2021.03.019
Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome
Abstract
Background: In human fetuses with Down syndrome, placental pathology, structural anomalies and growth restriction are present. There is currently a significant lack of information regarding the early life span in mouse models of Down syndrome.
Objective: The objective of this study was to examine embryonic day 18.5 and placental phenotype in the 3 most common mouse models of Down syndrome (Ts65Dn, Dp(16)1/Yey, Ts1Cje). Based on prenatal and placental phenotyping in 3 mouse models of Down syndrome, we hypothesized that one or more of them would have a similar phenotype to human fetuses with trisomy 21, which would make it the most suitable for in utero treatment studies.
Study design: Here, C57BL6J/6 female mice were mated to Dp(16)1/Yey and Ts1Cje male mice and Ts65Dn female mice to C57BL/B6Eic3Sn.BLiAF1/J male mice. At embryonic day 18.5, dams were euthanized. Embryos and placentas were examined blindly for weight and size. Embryos were characterized as euploid or trisomic, male or female by polymerase chain reaction. A subset of embryos (34 euploid and 34 trisomic) were examined for malformations.
Results: The Ts65Dn mouse model showed the largest differences in fetal growth, brain development, and placental development when comparing euploid and trisomic embryos. For the Dp(16)1/Yey mouse model, genotype did not impact fetal growth, but there were differences in brain and placental development. For the Ts1Cje mouse model, no significant association was found between genotype and fetal growth, brain development, or placental development. Euploid mouse embryos had no congenital anomalies; however, 1 mouse embryo died. Hepatic necrosis was seen in 6 of 12 Dp(16)1/Yey (50%) and 1 of 12 Ts1Cje (8%) mouse embryos; hepatic congestion or inflammation was observed in 3 of 10 Ts65Dn mouse embryos (30%). Renal pelvis dilation was seen in 5 of 12 Dp(16)1/Yey (42%), 5 of 10 Ts65Dn (50%), and 3 of 12 Ts1Cje (25%) mouse embryos. In addition, 1 Ts65Dn mouse embryo and 1 Dp(16)1/Yey mouse embryo had an aortic outflow abnormality. Furthermore, 2 Ts1Cje mouse embryos had ventricular septal defects. Ts65Dn mouse placentas had increased spongiotrophoblast necrosis.
Conclusion: Fetal and placental growth showed varying trends across strains. Congenital anomalies were primarily seen in trisomic embryos. The presence of liver abnormalities in all 3 mouse models of Down syndrome (10 of 34 cases) is a novel finding. Renal pelvis dilation was also common (13 of 34 cases). Future research will examine human autopsy material to determine if these findings are relevant to infants with Down syndrome. Differences in placental histology were also observed among strains.
Keywords: Down syndrome; fetal phenotyping; liver abnormalities; mouse models; placenta.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest: The authors report no conflict of interest.
Figures




Similar articles
-
Embryonic statistical analyses reveal 2 growth phenotypes in mouse models of Down syndrome.Am J Obstet Gynecol. 2024 Feb;230(2):258.e1-258.e11. doi: 10.1016/j.ajog.2023.07.056. Epub 2023 Aug 6. Am J Obstet Gynecol. 2024. PMID: 37544351 Free PMC article.
-
Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.Dis Model Mech. 2018 Jun 12;11(6):dmm031013. doi: 10.1242/dmm.031013. Dis Model Mech. 2018. PMID: 29716957 Free PMC article.
-
Visual discrimination and inhibitory control deficits in mouse models of Down syndrome: A pilot study using rodent touchscreen technology.J Neurosci Res. 2023 Apr;101(4):492-507. doi: 10.1002/jnr.25160. Epub 2023 Jan 5. J Neurosci Res. 2023. PMID: 36602162 Free PMC article.
-
Placental development and function in trisomy 21 and mouse models of Down syndrome: Clues for studying mechanisms underlying atypical development.Placenta. 2020 Jan 1;89:58-66. doi: 10.1016/j.placenta.2019.10.002. Epub 2019 Oct 5. Placenta. 2020. PMID: 31683073 Free PMC article. Review.
-
Placenta morphology and biomarkers in pregnancies with congenital heart disease - A systematic review.Placenta. 2021 Sep 1;112:189-196. doi: 10.1016/j.placenta.2021.07.297. Epub 2021 Aug 8. Placenta. 2021. PMID: 34388551
Cited by
-
Embryonic statistical analyses reveal 2 growth phenotypes in mouse models of Down syndrome.Am J Obstet Gynecol. 2024 Feb;230(2):258.e1-258.e11. doi: 10.1016/j.ajog.2023.07.056. Epub 2023 Aug 6. Am J Obstet Gynecol. 2024. PMID: 37544351 Free PMC article.
References
-
- de Graaf G, Buckley F, Dever J, et al.Estimation of live birth and population prevalence of Down syndrome in nine U.S. states. Am J Med Genet A. 2017;173(10):2710–2719. - PubMed
-
- Data and statistics on Down syndrome. Division of Birth Defects and Developmental Disabilities, NCBDDD, Centers for Disease Control and Prevention; Web site. https://www.cdc.gov/ncbddd/birthdefects/downsyndrome/data.html. Updated 2017.
-
- Guseh SH, Little SE, Bennett K, et al.Antepartum management and obstetric outcomes among pregnancies with Down syndrome from diagnosis to delivery. Prenat Diagn. 2017;37(7):640–646. - PubMed
-
- Sparks TN, Griffin E, Page J, et al.Down syndrome: Perinatal mortality risks with each additional week of expectant management. Prenat Diagn. 2016;36(4):368–374. - PubMed
-
- Wessels MW, Los FJ, Frohn-Mulder IM, et al.Poor outcome in Down syndrome fetuses with cardiac anomalies or growth retardation. Am J Med Genet A. 2003;116A(2): 147–151. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases